Literature DB >> 25291526

Risk factors for pancreatic neuroendocrine tumors: a clinic-based case-control study.

Thorvardur R Halfdanarson1, William R Bamlet, Robert R McWilliams, Timothy J Hobday, Patrick A Burch, Kari G Rabe, Gloria M Petersen.   

Abstract

OBJECTIVES: Pancreatic neuroendocrine tumors (PNETs) are uncommon, and little is known about their risk factors and association with other cancers. We evaluated whether the following risk factors known to be associated with pancreatic adenocarcinoma are also associated with PNETs: smoking, alcohol use, family history of PNET, and other cancers, and personal history of diabetes as potential risk factors.
METHODS: Patients with PNETs seen at Mayo Clinic Rochester between 2000 and 2011 were compared with controls seen for a general medical evaluation. Patients and controls completed the same questionnaires. After excluding insulinoma and high-grade PNETs, 355 cases were evaluated, and 309 were matched to 602 controls (2:1) on age, sex, and region of residence.
RESULTS: Personal smoking history was not associated with PNETs. Alcohol use was less common among cases (54% vs 67%, P < 0.001). Cases were more likely to report a family member with sarcoma (P = 0.02), PNET (P = 0.02), gallbladder cancer (P = 0.02), ovarian cancer (P = 0.04), and gastric cancer (P = 0.01). There was no association with other cancers in family members. Diabetes was more commonly reported by cases than controls (19% vs 11%, P < 0.001).
CONCLUSIONS: With the exception of diabetes, risk factors that are associated with pancreatic adenocarcinoma are not risk factors for PNETs.

Entities:  

Mesh:

Year:  2014        PMID: 25291526      PMCID: PMC4267883          DOI: 10.1097/MPA.0000000000000234

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  18 in total

1.  Glucose intolerance in the carcinoid syndrome.

Authors:  J M Feldman; J W Plonk; C H Bivens; H E Lebovitz
Journal:  Diabetes       Date:  1975-07       Impact factor: 9.461

Review 2.  Insulinoma.

Authors:  Clive S Grant
Journal:  Best Pract Res Clin Gastroenterol       Date:  2005-10       Impact factor: 3.043

3.  Zollinger-Ellison syndrome associated with a history of alcohol abuse: coincidence or consequence?

Authors:  Stuart D Wilson; Kara M Doffek; Elizabeth A Krzywda; Edward J Quebbeman; Kathleen K Christians; Sam G Pappas
Journal:  Surgery       Date:  2011-12       Impact factor: 3.982

Review 4.  The multiple endocrine neoplasia syndromes.

Authors:  Vipul T Lakhani; Y Nancy You; Samuel A Wells
Journal:  Annu Rev Med       Date:  2007       Impact factor: 13.739

5.  The importance of smoking and medical history for development of small bowel carcinoid tumor: a European population-based case-control study.

Authors:  Linda Kaerlev; Peter Stubbe Teglbjaerg; Svend Sabroe; Henrik A Kolstad; Wolfgang Ahrens; Mikael Eriksson; Pascal Guénel; Giuseppe Gorini; Lennart Hardell; Diane Cyr; Paola Zambon; Andreas Stang; Jorn Olsen
Journal:  Cancer Causes Control       Date:  2002-02       Impact factor: 2.506

6.  Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study.

Authors:  Lucio Gullo; Marina Migliori; Massimo Falconi; Paolo Pederzoli; Rossella Bettini; Riccardo Casadei; Gianfranco Delle Fave; Vito D Corleto; Claudio Ceccarelli; Donatella Santini; Paola Tomassetti
Journal:  Am J Gastroenterol       Date:  2003-11       Impact factor: 10.864

Review 7.  Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.

Authors:  Thorvardur R Halfdanarson; Joseph Rubin; Michael B Farnell; Clive S Grant; Gloria M Petersen
Journal:  Endocr Relat Cancer       Date:  2008-06       Impact factor: 5.678

8.  Risk factors for adenocarcinomas and malignant carcinoids of the small intestine: preliminary findings.

Authors:  C C Chen; A I Neugut; H Rotterdam
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994 Apr-May       Impact factor: 4.254

9.  Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors.

Authors:  Karl Y Bilimoria; David J Bentrem; Ryan P Merkow; James S Tomlinson; Andrew K Stewart; Clifford Y Ko; Mark S Talamonti
Journal:  J Am Coll Surg       Date:  2007-08-03       Impact factor: 6.113

10.  Family history of cancer and associated risk of developing neuroendocrine tumors: a case-control study.

Authors:  Manal M Hassan; Alexandria Phan; Donghui Li; Cecile G Dagohoy; Colleen Leary; James C Yao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-04       Impact factor: 4.254

View more
  21 in total

1.  Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data.

Authors:  Vanessa L Gordon-Dseagu; Susan S Devesa; Michael Goggins; Rachael Stolzenberg-Solomon
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 7.196

2.  Risk of Primary Neuroendocrine Pancreatic Tumor After a First Primary Cancer: A US Population-Based Study.

Authors:  Geetanjali R Kamath; Michelle K Kim; Emanuela Taioli
Journal:  Pancreas       Date:  2019-02       Impact factor: 3.327

Review 3.  The role of an anti-diabetic drug metformin in the treatment of endocrine tumors.

Authors:  Shilpa Thakur; Brianna Daley; Joanna Klubo-Gwiezdzinska
Journal:  J Mol Endocrinol       Date:  2019-08       Impact factor: 5.098

4.  Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective.

Authors:  Giovanna Muscogiuri; Barbara Altieri; Manuela Albertelli; Andrea Dotto; Roberta Modica; Luigi Barrea; Giuseppe Fanciulli; Tiziana Feola; Roberto Baldelli; Rosaria Maddalena Ruggeri; Marco Gallo; Valentina Guarnotta; Pasqualino Malandrino; Erika Messina; Mary Anna Venneri; Elisa Giannetta; Diego Ferone; Annamaria Colao; Antongiulio Faggiano
Journal:  Endocrine       Date:  2020-05-28       Impact factor: 3.633

5.  High pre-operative fasting blood glucose levels predict a poor prognosis in patients with pancreatic neuroendocrine tumour.

Authors:  Yitao Gong; Zhiyao Fan; Pin Zhang; Yunzhen Qian; Qiuyi Huang; Shengming Deng; Guopei Luo; He Cheng; Kaizhou Jin; Quanxing Ni; Xianjun Yu; Chen Liu
Journal:  Endocrine       Date:  2020-08-29       Impact factor: 3.633

6.  Evaluation of the risk factors associated with rectal neuroendocrine tumors: a big data analytic study from a health screening center.

Authors:  Jeung Hui Pyo; Sung Noh Hong; Byung-Hoon Min; Jun Haeng Lee; Dong Kyung Chang; Poong-Lyul Rhee; Jae Jun Kim; Sun Kyu Choi; Sin-Ho Jung; Hee Jung Son; Young-Ho Kim
Journal:  J Gastroenterol       Date:  2016-03-30       Impact factor: 7.527

Review 7.  Using Electronic Health Records for Population Health Research: A Review of Methods and Applications.

Authors:  Joan A Casey; Brian S Schwartz; Walter F Stewart; Nancy E Adler
Journal:  Annu Rev Public Health       Date:  2015-12-11       Impact factor: 21.981

8.  Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case-control study.

Authors:  T Feola; G Puliani; F Sesti; R Modica; R Centello; R Minotta; G Cannavale; S Di Meglio; V Di Vito; R Lauretta; M Appetecchia; A Colao; A Lenzi; A M Isidori; A Faggiano; E Giannetta
Journal:  J Endocrinol Invest       Date:  2022-01-18       Impact factor: 4.256

9.  Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors.

Authors:  Daniele Campa; Gabriele Capurso; Manuela Pastore; Renata Talar-Wojnarowska; Anna Caterina Milanetto; Luca Landoni; Evaristo Maiello; Rita T Lawlor; Ewa Malecka-Panas; Niccola Funel; Maria Gazouli; Antonio De Bonis; Harald Klüter; Maria Rinzivillo; Gianfranco Delle Fave; Thilo Hackert; Stefano Landi; Peter Bugert; Franco Bambi; Livia Archibugi; Aldo Scarpa; Verena Katzke; Christos Dervenis; Valbona Liço; Sara Furlanello; Oliver Strobel; Francesca Tavano; Daniela Basso; Rudolf Kaaks; Claudio Pasquali; Manuel Gentiluomo; Cosmeri Rizzato; Federico Canzian
Journal:  Sci Rep       Date:  2016-12-23       Impact factor: 4.379

10.  Implications of neuroendocrine tumor and diabetes mellitus on patient outcomes and care: a matched case-control study.

Authors:  Yael N Kusne; Heidi E Kosiorek; Matthew R Buras; Patricia M Verona; Kyle E Coppola; Kelley A Rone; Curtiss B Cook; Nina J Karlin
Journal:  Future Sci OA       Date:  2021-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.